Data Supplement from Combined SFK/mTOR Inhibition Prevents Rapamycin-Induced Feedback Activation of AKT and Elicits Efficient Tumor Regression
crossref(2023)
摘要
Supplementary Figure S6. The combination of dasatinib and rapamycin induces tumor regression of MMTV-PyMT-induced mammary tumors.
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要